Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Judith Romo, et al v. Teva Pharmaceuticals USA, Inc.
Case Number:
13-56310
Court:
Nature of Suit:
3365 Personal Injury-Product Liability
Companies
Sectors & Industries:
-
November 18, 2014
En Banc 9th Circ. Reverses Remand Of Teva Painkiller Suits
The Ninth Circuit sitting en banc reversed a panel decision on Tuesday remanding to California state court dozens of coordinated, multiplaintiff lawsuits alleging the pain medication propoxyphene caused cardiovascular injuries, after Teva Pharmaceuticals USA Inc. and Xanodyne Pharmaceuticals Inc. argued the cases were properly removed to federal court.
-
February 11, 2014
9th Circ. To Reconsider Its Remand Of Teva Painkiller Suit
The Ninth Circuit on Monday agreed to take another look at its remand to state court of a lawsuit against Teva Pharmaceuticals Inc. that's part of a mass action over cardiovascular injuries allegedly tied to propoxyphene painkillers after the drugmaker argued that the decision created a troubling circuit split.
-
September 24, 2013
9th Circ. Affirms Remand Of Painkiller Suit To State Court
The Ninth Circuit denied Teva Pharmaceuticals USA Inc.'s challenge of an order remanding to state court a lawsuit over cardiovascular injuries allegedly tied to propoxyphene painkillers, saying on Tuesday the plaintiffs' case coordination request didn't meet the requirements for removal under the Class Action Fairness Act.